AU2879292A - Peptides corresponding to antigenic determinants of htlv - Google Patents
Peptides corresponding to antigenic determinants of htlvInfo
- Publication number
- AU2879292A AU2879292A AU28792/92A AU2879292A AU2879292A AU 2879292 A AU2879292 A AU 2879292A AU 28792/92 A AU28792/92 A AU 28792/92A AU 2879292 A AU2879292 A AU 2879292A AU 2879292 A AU2879292 A AU 2879292A
- Authority
- AU
- Australia
- Prior art keywords
- htlv
- peptide
- amino acid
- acid sequence
- envelope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
- C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77155391A | 1991-10-08 | 1991-10-08 | |
| US771553 | 1991-10-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2879292A true AU2879292A (en) | 1993-05-03 |
Family
ID=25092199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU28792/92A Abandoned AU2879292A (en) | 1991-10-08 | 1992-10-08 | Peptides corresponding to antigenic determinants of htlv |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0618804A4 (fr) |
| JP (1) | JPH07502493A (fr) |
| AU (1) | AU2879292A (fr) |
| WO (1) | WO1993006843A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0643835B1 (fr) * | 1992-02-24 | 2001-04-18 | Genelabs Technologies, Inc. | Titrage de htlv-i/htlv-ii et procede |
| ATE496938T1 (de) * | 2002-12-20 | 2011-02-15 | Amgen Inc | Myostatin hemmende bindungsstoffe |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1262014A (fr) * | 1983-01-07 | 1989-09-26 | Mitsuaki Yoshida | Peptides relies au virus de la leucemie humaine, anticorps de ces peptides et procede de production de ceux-ci |
| US4724258A (en) * | 1984-02-03 | 1988-02-09 | Juridical Foundation, Japanese Foundation For Cancer Research | Adult T cell leukemia virus antigen polypeptide |
| US4663436A (en) * | 1984-04-24 | 1987-05-05 | Scripps Clinic And Research Foundation | Leukemia-associated virus immunogen, vaccine and assay |
| US4689398A (en) * | 1984-06-20 | 1987-08-25 | Ortho Diagnostic Systems Inc. | HTLV test using synthetic peptides |
| US4879212A (en) * | 1986-04-02 | 1989-11-07 | United Biomedical Inc. | Peptide composition and method for the detection of antibodies to HTLV-III |
| US4822606A (en) * | 1986-04-07 | 1989-04-18 | Duke University | Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences |
| US4833071A (en) * | 1987-01-09 | 1989-05-23 | United Biomedical, Inc. | Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor |
| JPH02209889A (ja) * | 1988-02-08 | 1990-08-21 | Univ Duke | 合成親水性ペプチド |
-
1992
- 1992-10-08 AU AU28792/92A patent/AU2879292A/en not_active Abandoned
- 1992-10-08 EP EP92922125A patent/EP0618804A4/fr not_active Withdrawn
- 1992-10-08 WO PCT/US1992/008405 patent/WO1993006843A1/fr not_active Ceased
- 1992-10-08 JP JP5507082A patent/JPH07502493A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0618804A1 (fr) | 1994-10-12 |
| JPH07502493A (ja) | 1995-03-16 |
| EP0618804A4 (fr) | 1995-06-07 |
| WO1993006843A1 (fr) | 1993-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5019387A (en) | Production of antibodies to HIV | |
| Palker et al. | Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins | |
| US5013548A (en) | Production of antibodies to HIV | |
| US5665536A (en) | Diagnastic method and test kit for the serological detection of the AIDS virus | |
| US5840313A (en) | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | |
| EP0550599B1 (fr) | Peptides destines a etre utilises dans la vaccination et dans l'induction d'anticorps neutralisants pour lutter contre le virus d'immunodeficience humaine | |
| WO1987002775A1 (fr) | Peptides synthetiques et leur utilisation pour le diagnostic et la vaccination contre le sida et son complexe associe | |
| HU214439B (hu) | Eljárás HIV-fertőzések kezelésére alkalmas monoklonális antitestek és peptidek, valamint ezeket tartalmazó gyógyászati készítmények és vakcinák előállítására | |
| HUT63179A (en) | Process for producing synthetic polypeptides | |
| US4956273A (en) | Synthetic peptides and method of use for diagnosis and vaccination for AIDS and ARC | |
| EP0246829B1 (fr) | Peptides relatifs au virus HTLV-III(LAV), anticorps contre les peptides, vaccins, immunisation passive et active contre le virus de SIDA, et test diagnostique pour la détection sérologique du virus de SIDA | |
| US5516632A (en) | Synthetic peptides | |
| EP0814090A1 (fr) | Peptides et anticorps dérivés pour le diagnose, la thérapie des, et la vaccination contre des infections de HTLV-1 | |
| AU1684495A (en) | Peptomers with enhanced immunogenicity | |
| US5346989A (en) | Peptides for use in induction of T cell activation against HIV-1 | |
| AU2879292A (en) | Peptides corresponding to antigenic determinants of htlv | |
| EP0551308A1 (fr) | Nouveaux antigenes peptidiques et immunoanalyses, kits de test et vaccins utilisant ces antigenes | |
| EP0693938B1 (fr) | Peptides utilises pour la vaccination et pour l'induction d'anticorps neutralisants diriges contre le virus d'immunodeficience humaine | |
| JPH02209889A (ja) | 合成親水性ペプチド | |
| IE67533B1 (en) | HIV related peptides | |
| Syennerholm et al. | Vahlne et al. | |
| HK1006921A (en) | Peptides and antibodies derived therefrom for the diagnosis of , therapy for and vaccination against htlv-1 infection |